摘要
Progressively,as chemotherapy has become more effective,more children with liver malignancies are amenable to liver transplantation,and indications have expanded from a limited range of cases(mostly hepatoblastoma)to a range of other unresectable malignant liver tumors;as a result,more children with hepatocellular carcinoma are also now proposed to transplantation,even and often outside the Milan criteria,for a cure.Recent series have highlighted that patient and graft survivals after transplantation for hepatoblastoma and hepatocellular carcinoma have improved in the last decade.Although consensus has not yet been reached about transplantation as a possible cure for other tumor types than hepatoblastoma and hepatocellular carcinoma,liver transplantation,generally speaking,has become an important pillar in the management of pediatric liver malignancies.Remaining limitations and inquiries relate to patient selection(in term of selection criteria considering the risk of recurrence),the role and usefulness of chemotherapy after transplantation,or the best immunosuppression strategy to both protect renal function and improve outcome.Although some prospective studies are on the way regarding these aspects,more studies are needed to explore this rapidly changing aspect of care.
